相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epigenomic charting and functional annotation of risk loci in renal cell carcinoma
Amin H. Nassar et al.
NATURE COMMUNICATIONS (2023)
Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance
Sonia Mazumder et al.
CANCERS (2023)
Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
BHLHE41 Overexpression Alleviates the Malignant Behavior of Colon Cancer Cells Induced by Hypoxia via Modulating HIF-1α/EMT Pathway
Sheng Chen et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2022)
METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer
Huarong Chen et al.
GASTROENTEROLOGY (2022)
BHLHE41/DEC2 Expression Induces Autophagic Cell Death in Lung Cancer Cells and Is Associated with Favorable Prognosis for Patients with Lung Adenocarcinoma
Toshiyuki Nagata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
MicroRNA-16 directly binds to DEC2 and inactivates the TLR4 signaling pathway to inhibit lupus nephritis-induced kidney tissue hyperplasia and mesangial cell proliferation
Huimeng Qi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Bhlhe40 and Bhlhe41 transcription factors regulate alveolar macrophage self-renewal and identity
Rene Rauschmeier et al.
EMBO JOURNAL (2019)
BHLHE41 promotes U87 and U251 cell proliferation via ERK/cyclinD1 signaling pathway
Chen Wang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
DEC2 modulates orexin expression and regulates sleep
Arisa Hirano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia
Akihiko Numata et al.
NATURE COMMUNICATIONS (2018)
Multiple renal cancer susceptibility polymorphisms modulate the HIF pathway
Steffen Grampp et al.
PLOS GENETICS (2017)
MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches
Amanda C. Winters et al.
FRONTIERS IN PEDIATRICS (2017)
Essential role for the transcription factor Bhlhe41 in regulating the development, self-renewal and BCR repertoire of B-1a cells
Taras Kreslavsky et al.
NATURE IMMUNOLOGY (2017)
The hypoxic tumor microenvironment: A driving force for breast cancer progression
Gregg L. Semenza
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
DEC2 is a negative regulator for the proliferation and differentiation of chondrocyte lineage-committed mesenchymal stem cells
Tomoko Sasamoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Roles of SHARP1 in thyroid cancer
Zun-Hai Zhou et al.
MOLECULAR MEDICINE REPORTS (2016)
Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41
Pierre Bigot et al.
NATURE COMMUNICATIONS (2016)
SUMO Signaling by Hypoxic Inactivation of SUMO-Specific Isopeptidases
Kathrin Kunz et al.
CELL REPORTS (2016)
DEC1 and DEC2 Crosstalk between Circadian Rhythm and Tumor Progression
Fuyuki Sato et al.
JOURNAL OF CANCER (2016)
Fibroblast growth factor signaling in skeletal development and disease
David M. Ornitz et al.
GENES & DEVELOPMENT (2015)
Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells
Kazuo Asanoma et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Involvement of c-Myc in the proliferation of MCF-7 human breast cancer cells induced by bHLH transcription factor DEC2
Yunyan Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia
Elena Manara et al.
BLOOD (2014)
Small Ubiquitin-like Modifier (SUMO) Protein-specific Protease 1 De-SUMOylates Sharp-1 Protein and Controls Adipocyte Differentiation
Bingting Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
USP17- and SCFβTrCP-Regulated Degradation of DEC1 Controls the DNA Damage Response
Jihoon Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
Xi Chen et al.
NATURE (2014)
A Novel BHLHE41 Variant is Associated with Short Sleep and Resistance to Sleep Deprivation in Humans
Renata Pellegrino et al.
SLEEP (2014)
Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
Aniruddha J. Deshpande et al.
BLOOD (2013)
Sumoylation of the Basic Helix-Loop-Helix Transcription Factor Sharp-1 Regulates Recruitment of the Histone Methyltransferase G9a and Function in Myogenesis
Yaju Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
Ester Sanchez-Tillo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
The basic helix-loop-helix transcription factor DEC2 inhibits TGF-β-induced tumor progression in human pancreatic cancer BxPC-3 cells
Fuyuki Sato et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors
Marco Montagner et al.
NATURE (2012)
SUMO Modification of Stra13 Is Required for Repression of Cyclin D1 Expression and Cellular Growth Arrest
Yaju Wang et al.
PLOS ONE (2012)
The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor
Yuxin Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
SUMOylation of DEC1 Protein Regulates Its Transcriptional Activity and Enhances Its Stability
Yongde Hong et al.
PLOS ONE (2011)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
SHARP1/DEC2 inhibits adipogenic differentiation by regulating the activity of C/EBP
Neriman Tuba Gulbagci et al.
EMBO REPORTS (2009)
Requirement for the basic helix-loop-helix transcription factor Dec2 in initial T(H)2 lineage commitment
Xuexian O. Yang et al.
NATURE IMMUNOLOGY (2009)
The Transcriptional Repressor DEC2 Regulates Sleep Length in Mammals
Ying He et al.
SCIENCE (2009)
Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression
Fuyuki Sato et al.
GENES TO CELLS (2008)
BHLHB3: a candidate tumor suppressor in lung cancer
F. S. Falvella et al.
ONCOGENE (2008)
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle
Roberta Morosetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter
Y. Li et al.
ONCOGENE (2006)
Sharp-1/DEC2 inhibits skeletal muscle differentiation through repression of myogenic transcription factors
S Azmi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
An overview of the basic helix-loop-helix proteins
S Jones
GENOME BIOLOGY (2004)
Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes
K Miyazaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Dec1 and Dec2 are regulators of the mammalian molecular clock
S Honma et al.
NATURE (2002)
HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron
SJ Mandriota et al.
CANCER CELL (2002)
Embryonic expression of mSharp-1/mDEC2, which encodes a basic helix-loop-helix transcription factor
S Azmi et al.
MECHANISMS OF DEVELOPMENT (2002)
分享论文
